Fu-Bo Wang (Fubo Wang)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Prostate Cancer

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Disease markers

Nature cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Wenhao Lu, Lin Zhao, Shenfan Wang, Huiyong Zhang, Kangxian Jiang, Jin Ji, Shaohua Chen, Chengbang Wang, Chunmeng Wei, Rongbin Zhou, Zuheng Wang, Xiao Li, Fu-Bo Wang, Xuedong Wei, Wenlei Hou
Explainable and visualizable machine learning models to predict biochemical recurrence of prostate cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Wenhao Lu, Lin Zhao, Shenfan Wang, Huiyong Zhang, Kangxian Jiang, Jin Ji, Shaohua Chen, Chengbang Wang, Chunmeng Wei, Rongbin Zhou, Zuheng Wang, Xiao Li, Fu-Bo Wang, Xuedong Wei, Wenlei Hou
Explainable and visualizable machine learning models to predict biochemical recurrence of prostate cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (9) (2024)
Xing He, Feng Tian, Fei Guo, Fangxing Zhang, Huiyong Zhang, Jin Ji, Lin Zhao, Jingyi He, Yutian Xiao, Longman Li, Chunmeng Wei, Caihong Huang, Yexin Li, Feng Zhang, Bo Yang, Huamao Ye, Fu-Bo Wang
Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma. BMC medicine 20 (1) (2022)
Huan Xu, Junyi Chen, Zhi Cao, Xi Chen, Caihong Huang, Jin Ji, Yalong Xu, Junfeng Jiang, Yue Wang, Guowang Xu, Lina Zhou, Jingyi He, Xuedong Wei, Jason Boyang Wu, Zhong Wang, Shancheng Ren, Fu-Bo Wang
Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy. Cancer biology & medicine 19 (9) (2022)
Chunmeng Wei, Xi Chen, Jin Ji, Yalong Xu, Xing He, Huiyong Zhang, Zengnan Mo, Fu-Bo Wang
UE-PSA is a non-invasive biomarker to detect prostate cancer: not only old wine in new bottles. International journal of cancer (2022)
Cheng-Bang Wang, Shao-Hua Chen, Lin Zhao, Xin Jin, Xi Chen, Jin Ji, Zeng-Nan Mo, Fu-Bo Wang
Urine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)
Zhi Cao, Xiaolei Shi, Feng Tian, Yu Fang, Jason Boyang Wu, Stefan Mrdenovic, Xinwen Nian, Jin Ji, Huan Xu, Chen Kong, Yalong Xu, Xi Chen, Yuhua Huang, Xuedong Wei, Yongwei Yu, Bo Yang, Leland W K Chung, Fu-Bo Wang
KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer. Cell death & disease 12 (1) (2021)
Jin Ji, Rui Chen, Lin Zhao, Yalong Xu, Zhi Cao, Huan Xu, Xi Chen, Xiaolei Shi, Yasheng Zhu, Ji Lyu, Junfeng Jiang, Yue Wang, Tie Zhou, Jingyi He, Xuedong Wei, Jason Boyang Wu, Bo Yang, Fu-Bo Wang
Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer. Molecular cancer 20 (1) (2021)
Sujun Chen, Guanghui Zhu, Yue Yang, Fu-Bo Wang, Yu-Tian Xiao, Na Zhang, Xiaojie Bian, Yasheng Zhu, Yongwei Yu, Fei Liu, Keqin Dong, Javier Mariscal, Yin Liu, Fraser Soares, Helen Loo Yau, Bo Zhang, Weidong Chen, Chao Wang, Dai Chen, Qinghua Guo, Zhengfang Yi, Mingyao Liu, Michael Fraser, Daniel D De Carvalho, Paul C Boutros, Dolores Di Vizio, Zhou Jiang, Theodorus H Van der Kwast, Alejandro Berlin, Song Wu, Jianhua Wang, Housheng Hansen He, Shancheng Ren
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nature cell biology 23 (1) (2021)
Zhi Cao, Yalong Xu, Fei Guo, Xi Chen, Jin Ji, Huan Xu, Jingyi He, Yongwei Yu, Yinghao Sun, Xin Lu, Fu-Bo Wang
FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer. Disease markers 2020 (2020)
Zhi Cao, Xi Chen, Yalong Xu, Fei Guo, Jin Ji, Huan Xu, Jingyi He, Yinghao Sun, Fu-Bo Wang
Differential Expression and Prognostic Value of Cytoplasmic and Nuclear Cyclin D1 in Prostate Cancer. BioMed research international 2020 (2020)